captopril has been researched along with Nephrosclerosis in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (66.67) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chávez, M; Herrera, J; Marín, C | 1 |
| Kincaid-Smith, P; Murphy, BF; Whitworth, JA | 1 |
| Fujimi, S; Hirakata, H; Iseki, K; Kumagai, H; Omae, T; Onoyama, K | 1 |
| Fujimi, S; Iseki, K; Omae, T; Onoyama, K | 1 |
| Ikenaga, H; Kanno, Y; Okada, H; Saruta, T; Suzuki, H | 1 |
| Onoyama, K | 1 |
| Hara, A; Kawai, C; Matsunaga, M; Nagai, H; Ohashi, H; Pak, CH; Yoshida, H | 1 |
| Mimran, A; Mion, CM; Mourad, G | 1 |
| Boner, G; Morduchowicz, G; Rosenfeld, JB; Rotenberg, Z; Shohat, J; Weinberger, I | 1 |
9 other study(ies) available for captopril and Nephrosclerosis
| Article | Year |
|---|---|
Transient improvement of hypertension-induced chronic renal failure with mycophenolate mofetil treatment.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Kidney Failure, Chronic; Mycophenolic Acid; Nephrosclerosis; Treatment Outcome | 2006 |
Renal insufficiency with combinations of angiotensin converting enzyme inhibitors and diuretics.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chlorothiazide; Dipeptides; Diuretics; Enalapril; Female; Furosemide; Humans; Kidney Diseases; Nephrosclerosis; Proline | 1984 |
Long-term hemodynamic response to captopril (SQ 14,225) in hypertensive hemodialysis patients.
Topics: Adult; Aged; Captopril; Glomerulonephritis; Hemodynamics; Humans; Hypertension; Male; Nephrosclerosis; Proline; Renal Dialysis; Time Factors | 1983 |
Immediate hemodynamic response to SQ 14225 (Captopril) in hypertensive and normotensive hemodialysis patients.
Topics: Adult; Captopril; Female; Glomerulonephritis; Hemodynamics; Humans; Hypertension; Male; Nephrosclerosis; Proline; Renal Dialysis; Renin | 1981 |
Nonpeptide angiotensin II type 1 receptor antagonist prevents nephrosclerosis in hypertensive rats.
Topics: Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Captopril; Glomerular Filtration Rate; Hypertension, Renal; Kidney; Nephrectomy; Nephrosclerosis; Prodrugs; Proteinuria; Rats; Rats, Inbred SHR; Renal Circulation; Tetrazoles | 1994 |
[Secondary kidney disease due to hypertension].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Humans; Hypertension, Renal; Nephrosclerosis; Nifedipine | 1992 |
Prevention of nephrosclerosis and cardiac hypertrophy by captopril treatment of spontaneously hypertensive rats.
Topics: Animals; Blood Urea Nitrogen; Captopril; Cardiomegaly; Complement C3; Hypertension; Immunoglobulin G; Kidney Glomerulus; Male; Myocardium; Nephrosclerosis; Organ Size; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System | 1986 |
Recovery of renal function in patients with accelerated malignant nephrosclerosis on maintenance dialysis with management of blood pressure by captopril.
Topics: Adolescent; Adult; Blood Pressure; Captopril; Creatinine; Female; Humans; Hypertension, Renal; Male; Nephrosclerosis; Renal Dialysis; Renin-Angiotensin System | 1985 |
Deterioration in renal function in patients with chronic renal failure after treatment with captopril.
Topics: Aged; Captopril; Humans; Hypertension; Kidney; Kidney Failure, Chronic; Male; Nephrosclerosis | 1985 |